Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89,126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index.
Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart PA, Karadag O, Kawa S, Kawano M, Kim MH, Lanzillotta M, Matsui S, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Tanasa P, Umehara H, Webster G, Zhang W, Stone JH. Wallace ZS, et al. Among authors: zhang w. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1671-1678. doi: 10.1002/acr.23543. Arthritis Care Res (Hoboken). 2018. PMID: 29457382 Free PMC article.
Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjögren's syndrome registry.
Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, Dong Y, Helin P, Kirkham BW, Li M, Sugai S, Umehara H, Vivino FB, Vollenweider CF, Zhang W, Zhao Y, Greenspan JS, Daniels TE, Criswell LA. Malladi AS, et al. Among authors: zhang w. Arthritis Care Res (Hoboken). 2012 Jun;64(6):911-8. doi: 10.1002/acr.21610. Epub 2012 Jan 11. Arthritis Care Res (Hoboken). 2012. PMID: 22238244 Free PMC article.
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Wang L, Zhang P, Wang M, Feng R, Lai Y, Peng L, Fei Y, Zhang X, Zhao Y, Zeng X, Zhang F, Zhang W. Wang L, et al. Among authors: zhang p, zhang f, zhang w, zhang x. Arthritis Res Ther. 2018 Apr 10;20(1):65. doi: 10.1186/s13075-018-1567-2. Arthritis Res Ther. 2018. PMID: 29636109 Free PMC article.
Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4-Related Disease.
Chen Y, Lin W, Yang H, Wang M, Zhang P, Feng R, Chen H, Peng L, Zhang X, Zhao Y, Zeng X, Zhang F, Zhang W, Lipsky PE. Chen Y, et al. Among authors: zhang p, zhang f, zhang w, zhang x. Arthritis Rheumatol. 2018 Nov;70(11):1853-1865. doi: 10.1002/art.40556. Epub 2018 Aug 29. Arthritis Rheumatol. 2018. PMID: 29781221 Free PMC article.
Sex disparities in clinical characteristics and prognosis of immunoglobulin G4-related disease: a prospective study of 403 patients.
Wang L, Zhang P, Zhang X, Lin W, Tang H, Li J, Wang M, Liu X, Fei Y, Chen H, Peng L, Zhang L, Lai Y, Zeng X, Li X, Xue H, Zhao Y, Zhang F, Zhang W. Wang L, et al. Among authors: zhang l, zhang p, zhang f, zhang w, zhang x. Rheumatology (Oxford). 2019 May 1;58(5):820-830. doi: 10.1093/rheumatology/key397. Rheumatology (Oxford). 2019. PMID: 30561747
Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy.
Wang M, Zhang P, Lin W, Fei Y, Chen H, Li J, Zhang L, Zheng W, Li Y, Zeng X, Zhou J, Lai Y, Liu X, Xue H, Cui Y, Zhou L, Zhao J, Zhang W. Wang M, et al. Among authors: zhang l, zhang p, zhang w. Arthritis Res Ther. 2019 Feb 1;21(1):44. doi: 10.1186/s13075-019-1828-8. Arthritis Res Ther. 2019. PMID: 30709411 Free PMC article.
Clinical outcomes and predictive relapse factors of IgG4-related disease following treatment: a long-term cohort study.
Peng Y, Li JQ, Zhang PP, Zhang X, Peng LY, Chen H, Zhou JX, Zhang SZ, Yang HX, Liu JJ, Guo HF, Li J, Zhang X, Zhao Y, Zeng XF, Zhang FC, Fei YY, Zhang W. Peng Y, et al. Among authors: zhang sz, zhang w, zhang fc, zhang pp, zhang x. J Intern Med. 2019 Nov;286(5):542-552. doi: 10.1111/joim.12942. Epub 2019 Jun 17. J Intern Med. 2019. PMID: 31121062 Free article.
Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4-related diseases: A prospective clinical trial.
Zhang P, Gong Y, Liu Z, Liu Y, Lin W, Li J, Wang M, Liu X, Fei Y, Chen H, Peng L, Li J, Zhou J, Shi Q, Zhang X, Shen M, Zeng X, Zhang F, Li Y, Zhao Y, Zhang W. Zhang P, et al. Among authors: zhang f, zhang w, zhang x. Int J Rheum Dis. 2019 Aug;22(8):1479-1488. doi: 10.1111/1756-185X.13633. Epub 2019 Jun 27. Int J Rheum Dis. 2019. PMID: 31245907 Free PMC article. Clinical Trial.
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Wallace ZS, et al. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. Ann Rheum Dis. 2020. PMID: 31796497 Review.
89,126 results
You have reached the last available page of results. Please see the User Guide for more information.